STO Equity Snapshot

XBRANE Weekly Equity Report

Xbrane Biopharma AB (publ)

Interactive chart JSON snapshot
Latest Close 10.70 SEK 12 Jun 2026
1W Return 0.0% latest completed week
4W Return -3.6% short-term follow-through
12W Return 79.9% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
Company Brief

What the company does

Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. It offers Ximluci, a ranibizumab biosimilar used for the treatment of various eye diseases, including wet form of age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and visual impairment due to cordial neovascularization in adults. The company also develops its pre-clinical phase products, such as Xdivane, a cell death 1 protein (PD1) inhibitor nivolumab biosimilar, indicated for melanoma, lung cancer, kidney cell cancer, head and neck cancer, and bladder and urinary tract cancer; and Xdarzane, a …

Snapshot

What the weekly tape is saying

XBRANE closed the latest completed week at 10.70 SEK. The 4-week return is -3.6% and the 12-week return is 79.9%. Trend Signal is inactive, Market Dynamics is 1.32. Setup signature: Risk-first tape with a 37/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 12.7%
Volume 0.8x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 18 Persistence of active Trend Signal over the last year and current streak.
Momentum 100 Blend of 4-week and 12-week follow-through.
Dynamics 73 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 32 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
9.49 SEK
Vs Trend Line
12.7%
Fair Value
122.0 SEK
Vs Fair Value
-91.2%
52W High
38.10 SEK
52W Low
5.42 SEK
Drawdown
-71.9%
Range Position
16.2%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W -3.6%
12W 79.9%
26W 4.7%
52W -64.6%

Trend read

Active Streak
0 weeks
52W Active Weeks
17
52W Active Breadth
32.7%
Sector Scope
SE Healthcare
Sector Rank
66 of 158
Sector Percentile
58.6%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.32
4W MD Change
-12.5%
Relative Strength
-46.60
4W RS Change
3.8%
Expectation
Negative
Probability
39.21%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
202.6K
13W Average
270.1K
52W Average
471.7K
Vs 13W
0.8x
Vs 52W
0.4x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
17.1%
52W Volatility
14.1%
Upside Weeks
23
Downside Weeks
27
Downside Breadth
51.9%
Avg Gain / Loss
9.0% / -9.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
STO
Country
SE
Sector
Healthcare
Industry
Biotechnology
Currency
SEK
Market Cap
212.2M

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 10.70 SEK 0.0% 9.49 SEK 122.0 SEK 1.32 -46.60 202.6K Off
5 Jun 2026 10.70 SEK 2.4% 9.47 SEK 129.1 SEK 1.38 -48.02 253.9K Off
29 May 2026 10.45 SEK -3.2% 9.45 SEK 136.0 SEK 1.41 -50.85 225.4K Off
22 May 2026 10.80 SEK -2.7% 9.46 SEK 143.0 SEK 1.45 -50.45 146.7K Off
15 May 2026 11.10 SEK 15.6% 9.48 SEK 150.2 SEK 1.50 -48.45 189.8K Off
8 May 2026 9.60 SEK -12.7% 9.88 SEK 157.6 SEK 1.49 -57.00 426.5K Off
1 May 2026 11.00 SEK 15.5% 10.67 SEK 165.2 SEK 1.12 -51.44 326.0K Off
24 Apr 2026 9.52 SEK -17.2% 11.40 SEK 173.2 SEK 0.71 -59.18 592.2K Off
17 Apr 2026 11.50 SEK 54.6% 12.14 SEK 181.6 SEK 0.22 -52.78 488.2K Off
10 Apr 2026 7.44 SEK 6.4% 12.85 SEK 190.1 SEK -0.24 -69.26 131.6K Off
3 Apr 2026 6.99 SEK 16.0% 13.64 SEK 199.0 SEK -0.29 -70.33 192.5K Off
27 Mar 2026 6.03 SEK 1.3% 14.50 SEK 207.9 SEK -0.28 -73.99 170.2K Off
20 Mar 2026 5.95 SEK -1.0% 15.51 SEK 215.6 SEK -0.06 -74.83 165.3K Off
13 Mar 2026 6.01 SEK 0.4% 16.50 SEK 222.9 SEK 0.10 -76.48 214.0K Off